Literature DB >> 8697155

Expression of platelet derived growth factor B chain and beta receptor in human coronary arteries after percutaneous transluminal coronary angioplasty: an immunohistochemical study.

S Tanizawa1, M Ueda, C M van der Loos, A C van der Wal, A E Becker.   

Abstract

OBJECTIVE: To evaluate whether expression of platelet derived growth factor B (PDGF-B) protein is associated with expression of its receptor protein in human coronary arteries after angioplasty and to identify cells involved.
BACKGROUND: PDGF is considered an important growth factor in the repair process of the vessel wall after angioplasty. In situ hybridisation has revealed expression of PDGF-A and -B chain messenger ribonucleic acid (mRNA) in human coronary arteries at sites of postangioplasty injury.
METHODS: Target and non-target sites of eight coronary arteries were studied immunohistochemically for PDGF-B and PDGF-beta receptor proteins in relation to macrophages, T lymphocytes, smooth muscle cells, and HLA-DR positive cells.
RESULTS: The PDGF-B and PDGF-beta receptor proteins were expressed in areas with distinct repair, containing alpha actin negative spindle cells, macrophages and, at later stages, alpha actin positive smooth muscle cells as well. When the neointima was composed mainly of alpha actin smooth muscle cells, PDGF-B expression was rare and PDGF-beta receptor expression was negative.
CONCLUSIONS: There is expression of PDGF-B and PDGF-beta receptor proteins at sites of postangioplasty repair in human coronary arteries. The associated cells are mainly macrophages and alpha actin negative spindle cells; the latter may be dedifferentiated smooth muscle cells. A link between PDGF expression and the postangioplasty time interval suggests a relation with cell differentiation as part of the maturation of the repair tissue. Mutual expression of both the growth factor and its receptor protein strongly suggests that in humans a PDGF mediated repair process occurs, with involvement of smooth muscle cells and macrophages.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8697155      PMCID: PMC484375          DOI: 10.1136/hrt.75.6.549

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  26 in total

1.  Differential regulation of expression of two platelet-derived growth factor receptor subunits by transforming growth factor-beta.

Authors:  R G Gronwald; R A Seifert; D F Bowen-Pope
Journal:  J Biol Chem       Date:  1989-05-15       Impact factor: 5.157

2.  Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization.

Authors:  J N Wilcox; K M Smith; L T Williams; S M Schwartz; D Gordon
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

3.  Characterization of two monoclonal antibodies reactive with the external domain of the platelet-derived growth factor receptor.

Authors:  L Rönnstrand; L Terracio; L Claesson-Welsh; C H Heldin; K Rubin
Journal:  J Biol Chem       Date:  1988-07-25       Impact factor: 5.157

4.  Pathological changes induced by repeated percutaneous transluminal coronary angioplasty.

Authors:  M Ueda; A E Becker; T Fujimoto
Journal:  Br Heart J       Date:  1987-12

5.  Transluminal coronary angioplasty and early restenosis. Fibrocellular occlusion after wall laceration.

Authors:  C E Essed; M Van den Brand; A E Becker
Journal:  Br Heart J       Date:  1983-04

6.  Endothelial cell hyperplasia in human glioblastoma: coexpression of mRNA for platelet-derived growth factor (PDGF) B chain and PDGF receptor suggests autocrine growth stimulation.

Authors:  M Hermansson; M Nistér; C Betsholtz; C H Heldin; B Westermark; K Funa
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

7.  Rat brain capillary endothelial cells express functional PDGF B-type receptors.

Authors:  A Smits; M Hermansson; M Nistér; I Karnushina; C H Heldin; B Westermark; K Funa
Journal:  Growth Factors       Date:  1989       Impact factor: 2.511

8.  Smooth muscle cell de-differentiation is a fundamental change preceding wound healing after percutaneous transluminal coronary angioplasty in humans.

Authors:  M Ueda; A E Becker; T Naruko; A Kojima
Journal:  Coron Artery Dis       Date:  1995-01       Impact factor: 1.439

9.  Arterial changes after percutaneous transluminal coronary angioplasty: results at autopsy.

Authors:  K Kohchi; S Takebayashi; P C Block; T Hiroki; M Nobuyoshi
Journal:  J Am Coll Cardiol       Date:  1987-09       Impact factor: 24.094

10.  Induction of B-type receptors for platelet-derived growth factor in vascular inflammation: possible implications for development of vascular proliferative lesions.

Authors:  K Rubin; A Tingström; G K Hansson; E Larsson; L Rönnstrand; L Klareskog; L Claesson-Welsh; C H Heldin; B Fellström; L Terracio
Journal:  Lancet       Date:  1988-06-18       Impact factor: 79.321

View more
  18 in total

1.  Smooth Muscle Cell-targeted RNA Aptamer Inhibits Neointimal Formation.

Authors:  William H Thiel; Carla L Esposito; David D Dickey; Justin P Dassie; Matthew E Long; Joshua Adam; Jennifer Streeter; Brandon Schickling; Maysam Takapoo; Katie S Flenker; Julia Klesney-Tait; Vittorio de Franciscis; Francis J Miller; Paloma H Giangrande
Journal:  Mol Ther       Date:  2016-01-06       Impact factor: 11.454

2.  Role of endothelial cell denudation and smooth muscle cell dedifferentiation in neointimal formation of human vein grafts after coronary artery bypass grafting: therapeutic implications.

Authors:  Y Sasaki; S Suehiro; A E Becker; H Kinoshita; M Ueda
Journal:  Heart       Date:  2000-01       Impact factor: 5.994

3.  Plasma BDNF and PDGF-AA levels are associated with high TCD velocity and stroke in children with sickle cell anemia.

Authors:  Hyacinth I Hyacinth; Beatrice E Gee; Thomas V Adamkiewicz; Robert J Adams; Abdullah Kutlar; Jonathan K Stiles; Jacqueline M Hibbert
Journal:  Cytokine       Date:  2012-06-15       Impact factor: 3.861

4.  PDGF-induced vascular smooth muscle cell proliferation is associated with dysregulation of insulin receptor substrates.

Authors:  Yan Zhao; Swarajit K Biswas; Patrick H McNulty; Mark Kozak; John Y Jun; Lakshman Segar
Journal:  Am J Physiol Cell Physiol       Date:  2011-02-16       Impact factor: 4.249

Review 5.  Induction of vascular atrophy as a novel approach to treating restenosis. A review.

Authors:  Seung-Kee Min; Richard D Kenagy; Alexander W Clowes
Journal:  J Vasc Surg       Date:  2007-10-22       Impact factor: 4.268

6.  ACE inhibitor quinapril reduces the arterial expression of NF-kappaB-dependent proinflammatory factors but not of collagen I in a rabbit model of atherosclerosis.

Authors:  M A Hernández-Presa; C Bustos; M Ortego; J Tuñón; L Ortega; J Egido
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

7.  C-reactive protein and vein graft disease: evidence for a direct effect on smooth muscle cell phenotype via modulation of PDGF receptor-beta.

Authors:  Karen J Ho; Christopher D Owens; Thomas Longo; Xin X Sui; Cristos Ifantides; Michael S Conte
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-07-11       Impact factor: 4.733

8.  Sp1-dependent activation of KLF4 is required for PDGF-BB-induced phenotypic modulation of smooth muscle.

Authors:  Rebecca A Deaton; Qiong Gan; Gary K Owens
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-01-23       Impact factor: 4.733

9.  Imatinib improves insulin resistance and inhibits injury-induced neointimal hyperplasia in high fat diet-fed mice.

Authors:  Prahalathan Pichavaram; Noha M Shawky; Thomas J Hartney; John Y Jun; Lakshman Segar
Journal:  Eur J Pharmacol       Date:  2020-10-24       Impact factor: 4.432

10.  Preventive Effect and Mechanism of Crossostephium chinense Extract on Balloon Angioplasty-Induced Neointimal Hyperplasia.

Authors:  Chun-Hsu Pan; Yu-Pei Lin; Jie-Yu Wang; Hui-Yu Huang; Shun-Cheng Huang; Ji-Mehng Lo; Chieh-Hsi Wu
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-30       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.